Tue, August 16, 2022


FDA issues warning about supplement claiming to enhance sexual performance

Blue M Gold, a food supplement widely advertised on its website and social media as increasing sexual libido, has been propagating its benefits without permission from Thailand’s Food and Drug Administration (FDA), the drug agency said on Friday, warning people against believing the claims as they could be dangerous.

FDA deputy secretary-general Dr Poonlarp Chantavichitwong said that the FDA had investigated and found the product had been registered as a food supplement. He said the licence for the production facility was now being suspended.
“FDA is currently dealing with advertisements that violate the law,” he said. “Taking supplements cannot improve sexual performance, so consumers should consider the facts before buying it.”
Previously, the FDA had found that most of these kinds of supplements contained sildenafil, a medication used to treat erectile dysfunction which is classified as a specially controlled drug and must be used under the supervision of a doctor.
The most common adverse effects of sildenafil include headache and flushing. Patients with coronary artery disease who take nitrate drugs could suffer from low blood pressure, causing even shock and death.
“We would like to warn consumers to be cautious and not blindly believe in this advertisement, as it could have dangerous effects,” said Dr Poonlarp.
“If you find any dangerous and suspicious products, you can submit a complaint via FDA hotline 1556, e-mail [[email protected]](mail to:[email protected]), or PO Box 1556, Ministry of Public Health 11004. Alternately, report your complaints via Or Yor Smart Application mobile app, or contact the provincial health office nationwide.”
The deputy secretary-general added that advertising or exaggerating medicinal benefits without FDA approval via various media is considered an offence, with punishment ranging from Bt5,000 to Bt30,000 fine or up to three years’ imprisonment, or both,” he added.

Published : November 15, 2019

By : The Nation